1. Home
  2. NVCR vs CHCO Comparison

NVCR vs CHCO Comparison

Compare NVCR & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • CHCO
  • Stock Information
  • Founded
  • NVCR 2000
  • CHCO 1957
  • Country
  • NVCR Jersey
  • CHCO United States
  • Employees
  • NVCR N/A
  • CHCO N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • CHCO Major Banks
  • Sector
  • NVCR Health Care
  • CHCO Finance
  • Exchange
  • NVCR Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • NVCR 2.1B
  • CHCO 1.7B
  • IPO Year
  • NVCR 2015
  • CHCO N/A
  • Fundamental
  • Price
  • NVCR $16.88
  • CHCO $115.32
  • Analyst Decision
  • NVCR Hold
  • CHCO Hold
  • Analyst Count
  • NVCR 5
  • CHCO 3
  • Target Price
  • NVCR $25.80
  • CHCO $104.67
  • AVG Volume (30 Days)
  • NVCR 1.1M
  • CHCO 40.3K
  • Earning Date
  • NVCR 10-24-2024
  • CHCO 10-22-2024
  • Dividend Yield
  • NVCR N/A
  • CHCO 2.48%
  • EPS Growth
  • NVCR N/A
  • CHCO 1.10
  • EPS
  • NVCR N/A
  • CHCO 7.76
  • Revenue
  • NVCR $549,964,000.00
  • CHCO $287,617,000.00
  • Revenue This Year
  • NVCR $16.23
  • CHCO N/A
  • Revenue Next Year
  • NVCR $6.09
  • CHCO $0.65
  • P/E Ratio
  • NVCR N/A
  • CHCO $14.86
  • Revenue Growth
  • NVCR 8.33
  • CHCO 2.36
  • 52 Week Low
  • NVCR $10.87
  • CHCO $86.56
  • 52 Week High
  • NVCR $24.74
  • CHCO $125.54
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 42.46
  • CHCO 47.99
  • Support Level
  • NVCR $16.11
  • CHCO $117.04
  • Resistance Level
  • NVCR $19.09
  • CHCO $119.90
  • Average True Range (ATR)
  • NVCR 1.23
  • CHCO 2.23
  • MACD
  • NVCR -0.10
  • CHCO -0.06
  • Stochastic Oscillator
  • NVCR 18.88
  • CHCO 20.66

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About CHCO City Holding Company

City Holding Co is a financial holding company. It provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, saving accounts, credit card and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance, technology products, and others. These products and services are provided to commercial banking, consumer banking, mortgage banking, wealth management, and trust services.

Share on Social Networks: